Skip to content

Clinical trials

Completed Lysosomal Storage Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Status: Completed Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20083
20093
20101
20118
20122
20131
20144
20153
20161
20172
20181
20194
20203
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.6
Shire5
Amicus Therapeutics3
BioMarin Pharmaceutical3
Ultragenyx Pharmaceutical Inc3
Duke University2
National Institute of Neurological Disorders and Stroke (NINDS)2
University of California, San Diego2
Azafaros B.V.1
Denali Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases43
Metabolic Diseases9
Mucopolysaccharidosis II8
Metabolism, Inborn Errors7
Genetic Diseases, Inborn6
Mucopolysaccharidoses6
Sudden Infant Death6
Wolman Disease6
Cholesterol Ester Storage Disease5
Gangliosidosis, GM14

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.